Catalyst Wire Dossier Catalyst Wire Dossier

Sebivo

telbivudine
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Sebivo, covering 2008-02-14 to 2021-01-14. Get the full timeline:

Most recent: EMA Withdrawn: Sebivo (telbivudine) — Novartis Europharm Limited

See pricing